Evidence map›Paper›PMID 30937131›Full record

ArticleThe World Allergy Organization journal2019

Edible insects: Cross-recognition of IgE from crustacean- and house dust mite allergic patients, and reduction of allergenicity by food processing.

Isabella Pali-Schöll, Pia Meinlschmidt, Désireé Larenas-Linnemann, Benedict Purschke, Gerlinde Hofstetter, Fernanda A Rodríguez-Monroy, Lukas Einhorn, Nadine Mothes-Luksch, Erika Jensen-Jarolim, Henry Jäger

Open access · goldAbstract read
In one paragraph

Article in The World Allergy Organization journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 110 citations in OpenAlex.

  1. Biological activities and safety assessment ofInternational journal of pharmaceutics: X · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Feasibility of UsingFoods (Basel, Switzerland) · 2025
    Review
  6. Review
  7. [Novel foods-What must be considered?]Dermatologie (Heidelberg, Germany) · 2025
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Isabella Pali-SchöllComparative Medicine, The Interuniversity Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna and University Vienna, Austria.
Pia MeinlschmidtDepartment of Food Science and Technology, Institute of Food Technology, University of Natural Resources and Life Sciences (BOKU) Vienna, Vienna, Austria.
Désireé Larenas-LinnemannCenter of Excellence in Asthma and Allergy, Hospital Médica Sur, México City, Mexico.
Benedict PurschkeDepartment of Food Science and Technology, Institute of Food Technology, University of Natural Resources and Life Sciences (BOKU) Vienna, Vienna, Austria.
Gerlinde HofstetterComparative Medicine, The Interuniversity Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna and University Vienna, Austria.
Fernanda A Rodríguez-MonroyCenter of Excellence in Asthma and Allergy, Hospital Médica Sur, México City, Mexico.
Lukas EinhornComparative Medicine, The Interuniversity Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna and University Vienna, Austria.
Nadine Mothes-LukschAllergyCare, Allergy Diagnosis and Study Center Vienna, Vienna, Austria.
Erika Jensen-JarolimComparative Medicine, The Interuniversity Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna and University Vienna, Austria.
Henry JägerDepartment of Food Science and Technology, Institute of Food Technology, University of Natural Resources and Life Sciences (BOKU) Vienna, Vienna, Austria.
University of Veterinary Medicine Vienna · ATBOKU University · ATHospital Médica Sur · MXAllergiezentrum Wien West · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInsects have become increasingly interesting as alternative nutrient sources for feeding humans and animals, most reasonably in processed form. Initially, some safety aspects - among them allergenicity - need to be addressed.

objectiveTo reveal the cross-reactivity of shrimp-, mite- and flies-allergic patients to different edible insects, and further to assess the efficacy of food processing in reducing the recognition of insect proteins by patients' IgE and in skin prick testing of shrimp-allergic patients.

methodsIgE from patients allergic to crustaceans, house dust mite or flies was evaluated for cross-recognition of proteins in house cricket

resultsIgE from patients with crustacean-allergy shows cross-recognition of AD, SG and stable flies; house dust mite allergics' IgE binds to AD and SG; and the flies-allergic patient recognized cricket, desert locust and migratory locust. Cross-reactivity and allergenicity in SPT to LM can be deleted by conventional processing steps, such as hydrolysis with different enzymes or heat treatment, during the preparation of protein concentrates.

conclusionThe results show that crustacean-, HDM- and stable flies-allergic patients cross-recognize desert locust and house cricket proteins, and crustacean-allergic patients also flies proteins. Furthermore, this study shows that appropriate food processing methods can reduce the risk of cross-reactivity and allergenicity of edible insects.

Indexed as

AllergenicityCross-recognitionEdible insectsEnzymatic hydrolysisFood allergyImmunoreactivityThermal processing

Identifiers

PMID30937131
PMCPMC6439408
OpenAlexW2911518610

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.